Tezspire: Expiry of patents related to polypeptides in EU on Sep 9, 2028 and US on Feb 3, 2029 (Amgen) - Feb 17, 2024 - Annual Report 2023: Expiry of patents related to methods of treatment in US on Aug 23, 2038
Patent • Asthma • Dermatology • Immunology • Respiratory Diseases
|